Loading company…
Ningju Biological develops hemostatic sealing and medical repair materials.
Founded in 2022 and based in Shenzhen, China, Ningju Biological develops biomedical materials. Its products include hemostatic sealing and repair materials for bleeding and injury care. The company raised Series A funding from Triwise Capital in September 2024 to develop its products and expand its market.
Funding rounds, investors and people for this company come from licensed data. A free account shows the first rows of each section; an approved contribution opens every profile in full.
Sign in